MAPT and Alzheimer disease: Leveraging 1370 tau-PET scan visits from 832 ADNI participants across the Alzheimer’s disease spectrum, we characterized the spatial extent of tau pathology across the whole brain (70 brain regions) both cross-sectionally and longitudinally.